Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of ONTO1 in Lupus

NCT07107659 is registered in ClinicalTrials.gov with Hospital for Special Surgery, New York as lead sponsor.

NCT NCT07107659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07107659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of ONTO1 in Lupus
Lead sponsor
Hospital for Special Surgery, New York
Phase
Phase 1
Overall status
Recruiting
Start date
September 4, 2026
Completion date
May 31, 2030
Enrollment
61 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lupus, lupus nephritis (ln), lupus nephritis - who class iii, lupus nephritis - who class iv, lupus nephritis - world health organization (who) class iii, sle, systemic lupus erythematosus, systemic lupus erythematosus (disorder)